Xylem Inc. (XYL) Sets New 52-Week High at $47.10
Xylem Inc. (NYSE:XYL) shares hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $47.10 and last traded at $47.01, with a volume of 494,934 shares. The stock had previously closed at $46.41.
Several research analysts recently issued reports on the company. Canaccord Genuity reissued a “hold” rating and issued a $42.00 price objective on shares of Xylem in a research note on Wednesday, May 4th. Oppenheimer Holdings Inc. restated an “outperform” rating on shares of Xylem in a report on Tuesday, April 19th. Wedbush upped their target price on Xylem from $41.00 to $43.00 and gave the stock a “neutral” rating in a report on Wednesday, May 4th. Zacks Investment Research upgraded Xylem from a “hold” rating to a “buy” rating and set a $46.00 target price for the company in a report on Wednesday, April 6th. Finally, Royal Bank Of Canada upgraded Xylem from a “sector perform” rating to an “outperform” rating and upped their target price for the stock from $37.00 to $42.00 in a report on Wednesday, June 1st. Eight analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Xylem presently has a consensus rating of “Hold” and an average target price of $41.58.
The stock has a 50-day moving average price of $45.32 and a 200 day moving average price of $40.41. The stock has a market capitalization of $8.43 billion and a P/E ratio of 24.90.
Xylem (NYSE:XYL) last posted its earnings results on Tuesday, May 3rd. The company reported $0.35 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.34 by $0.01. The company earned $847 million during the quarter, compared to analyst estimates of $832.03 million. The firm’s revenue for the quarter was up 1.2% on a year-over-year basis. During the same quarter last year, the business posted $0.33 EPS. Equities research analysts forecast that Xylem Inc. will post $2.05 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Wednesday, June 22nd. Investors of record on Wednesday, May 25th were issued a $0.1549 dividend. The ex-dividend date was Monday, May 23rd. This represents a $0.62 annualized dividend and a yield of 1.31%.
In related news, Director Steven R. Loranger sold 50,000 shares of Xylem stock in a transaction that occurred on Wednesday, June 1st. The shares were sold at an average price of $44.52, for a total value of $2,226,000.00. Following the completion of the sale, the director now owns 12,588 shares in the company, valued at approximately $560,417.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Colin R. Sabol sold 39,265 shares of Xylem stock in a transaction that occurred on Thursday, May 12th. The shares were sold at an average price of $42.91, for a total transaction of $1,684,861.15. Following the completion of the sale, the senior vice president now owns 62,885 shares of the company’s stock, valued at approximately $2,698,395.35. The disclosure for this sale can be found here.
Other hedge funds recently bought and sold shares of the company. SECOR Capital Advisors LP increased its stake in Xylem by 166.6% in the fourth quarter. SECOR Capital Advisors LP now owns 28,865 shares of the company’s stock valued at $1,054,000 after buying an additional 18,038 shares during the period. GAM Holding AG increased its position in Xylem by 4.6% in the fourth quarter. GAM Holding AG now owns 31,899 shares of the company’s stock valued at $1,164,000 after buying an additional 1,412 shares during the period. Aberdeen Asset Management PLC UK increased its position in Xylem by 24.9% in the fourth quarter. Aberdeen Asset Management PLC UK now owns 35,358 shares of the company’s stock valued at $1,259,000 after buying an additional 7,040 shares during the period. Hemenway Trust Co LLC increased its position in Xylem by 8.5% in the fourth quarter. Hemenway Trust Co LLC now owns 36,616 shares of the company’s stock valued at $1,336,000 after buying an additional 2,875 shares during the period. Finally, Stevens Capital Management LP acquired a new position in Xylem during the fourth quarter valued at approximately $1,474,000.
Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.